FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Aditxt's Free Cash Flow for the
three
months ended in Dec. 2023 was $-3.31 Mil. Aditxt's Revenue for the
three
months ended in Dec. 2023 was $0.08 Mil. Therefore, Aditxt's FCF Margin % for the quarter that ended in Dec. 2023 was -4,085.19%.
The historical rank and industry rank for Aditxt's FCF Margin % or its related term are showing as below:
ADTX'
s FCF Margin % Range Over the Past 10 Years
Min: -22184.76 Med: -2882.33 Max: -2436.72
Current: -2886.8
During the past 7 years, the highest FCF Margin % of Aditxt was -2436.72%. The lowest was -22184.76%. And the median was -2882.33%.
ADTX's FCF Margin % is ranked worse than 84.51% of 1046
companies
in the Biotechnology industry
Industry Median: -145.305
vs ADTX: -2886.80
Aditxt FCF Margin % Historical Data
The historical data trend for Aditxt's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Aditxt's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aditxt's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aditxt's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Aditxt's FCF Margin % falls into.
Aditxt FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Aditxt's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aditxt FCF Margin % Related Terms
Thank you for viewing the detailed overview of Aditxt's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes a tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADTX has been successfully added to your 